AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2019
Nov 26, 2019
30136_dirs_2019-11-26_bf7b18bb-74f1-4dc5-975a-a602b598172d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2019-11-01
Reporting Person: Griggs James M (SVP & Corp Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-01 | Common Stock | A | 180.0000 | $0.0000 | Acquired | 3927.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-01 | Stock Option/Right to Buy | $138.7000 | A | 722.0000 | Acquired | 2029-11-01 | Common Stock (722.0000) | Direct |
Footnotes
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 11/1/2022.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 11/1/2020.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26